New pill shows superior cholesterol reduction compared to statins

dailymail.co.uk

A new oral medication significantly lowers LDL cholesterol by over 57%, outperforming traditional statins. The drug, enlicitide, works by inhibiting the PCSK9 protein, a novel mechanism previously only available via injection. This offers a new strategy for patients with genetic high cholesterol. This development, published in the New England Journal of Medicine, could benefit millions of Americans at risk for heart disease and stroke if approved by the FDA.


With a significance score of 2.6, this news ranks in the top 16% of today's 30649 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: